Stay updated on Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded state-level Locations (California, Kansas, Massachusetts, New York, Texas, Washington) and removed the corresponding state locations; Revision: v3.3.3.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check38 days agoChange DetectedThe government funding/operating status notice that previously appeared on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedThe two screenshots show no meaningful differences; the Study Details page and its key sections appear unchanged.SummaryDifference0.3%

- Check82 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.0%

Stay in the know with updates to Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.